Skip to main content
Premium Trial:

Request an Annual Quote

Gentris Taps BioFortis' Software to Manage Biorepository Data

Premium

Gentris has selected BioFortis' Labmatrix and Qiagram software to manage samples and data collection and integration activities in its biorepository.

BioFortis' Labmatrix and Qiagram software were developed to integrate and query information from multiple sources including biomarker, translational, clinical, and healthcare data. They will provide Gentris' clients with tools to view and manage samples housed in the Gentris biorepository as well as enable them collect, harmonize, and integrate multiple data types including clinical, molecular, patient, and biospecimen data.

The financial details of the agreement were not disclosed.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.